#United States #New York #Securities #ClassAction #PepGen

PepGen Inc. Class Action Overview

PepGen Inc., a biopharmaceutical company based in the United States, is currently facing a class action lawsuit. Shareholders who acquired shares of PepGen (NASDAQ: PEPG) during the specified class period are being encouraged to participate in this legal action. This initiative has been emphasized by The Gross Law Firm, which has brought this matter to the forefront of investors’ attention.

Key Details of the Class Action

The class action covers shares bought between March 7, 2024, and March 3, 2025. Investors who purchased during this timeframe may have grounds for demonstrating that the company provided misleading information regarding its product efficacy and safety during the stages of development.

Allegations Against PepGen Inc.

According to the allegations, PepGen's management made several statements suggesting that their lead product candidate, PGN-EDO51, was more effective and safer than was actually the case. Specific claims include:
1. Misleading Statements: PepGen allegedly communicated that PGN-EDO51 was achieving positive results in clinical trials when evidence suggested otherwise.
2. Concerns Regarding Clinical Trials: The phase two CONNECT2 study reportedly faced significant issues, raising safety concerns that could jeopardize future FDA approval.
3. Exaggerated Prospects: The anticipated clinical and commercial viability of PGN-EDO51 may have been overstated, leading to inflated stock values that do not reflect the true state of the company.

These allegations pose serious challenges not only for PepGen but also for shareholders who trusted the company's disclosure and investment potential.

Important Dates and Next Steps

The deadline for potential lead plaintiff applications is set for August 8, 2025. Shareholders interested in participating in this class action must act quickly to secure their positions. It is recommended that those eligible register their information promptly. Registration will also include access to portfolio monitoring software, keeping investors informed of the case's progress.

Why Choose Gross Law Firm?

The Gross Law Firm is known for its commitment to protecting shareholder rights and ensuring accountability among corporations regarding their public statements and ethical obligations. This law firm's mission is to support institutional and individual investors suffering losses due to corporate malfeasance by providing legal avenues for recovery and justice.

If you believe you have been affected by the alleged actions of PepGen Inc., you can reach out to The Gross Law Firm directly to discuss your options. There are no costs associated with registering as a lead plaintiff or participating in the lawsuit, affirming the law firm's commitment to making this process accessible for all impacted shareholders.

Conclusion

As the situation for PepGen Inc. unfolds, it remains critical for investors to remain vigilant and proactive in protecting their interests. The upcoming deadline for the class action lawsuit offers a vital opportunity for those affected to seek recovery and hold the company accountable for its alleged misleading statements. Shareholders should not delay in registering their claims and ensure their voices are heard in this significant legal battle.